Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine.

Gijsman H, Kramer MS, Sargent J, Tuchman M, Matzura-Wolfe D, Polis A, Teall J, Block G, Ferrari MD.

Cephalalgia. 1997 Oct;17(6):647-51.

PMID:
9350384
2.

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.

Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD.

Arch Neurol. 1996 Nov;53(11):1132-7.

PMID:
8912486
3.

Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.

Teall J, Tuchman M, Cutler N, Gross M, Willoughby E, Smith B, Jiang K, Reines S, Block G.

Headache. 1998 Apr;38(4):281-7.

PMID:
9595867
4.

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.

Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R; Rizatriptan Protocol 059 and 061 Study Groups.

Headache. 2004 Oct;44(9):891-9.

PMID:
15447698
5.

Rizatriptan: a review of its efficacy in the management of migraine.

Dooley M, Faulds D.

Drugs. 1999 Oct;58(4):699-723. Review.

PMID:
10551439
6.

Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group.

Pascual J, Vega P, Diener HC, Allen C, Vrijens F, Patel K.

Cephalalgia. 2000 Jun;20(5):455-61.

PMID:
11037741
7.

Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.

Bomhof M, Paz J, Legg N, Allen C, Vandormael K, Patel K.

Eur Neurol. 1999;42(3):173-9.

PMID:
10529545
8.

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.

Winner P, Lewis D, Visser WH, Jiang K, Ahrens S, Evans JK; Rizatriptan Adolescent Study Group.

Headache. 2002 Jan;42(1):49-55.

PMID:
12005275
9.

Pilot study of MK-462 in migraine.

Cutler NR, Claghorn J, Sramek JJ, Block G, Panebianco D, Cheng H, Olah TV, Reines SA.

Cephalalgia. 1996 Apr;16(2):113-6.

PMID:
8665577
10.

Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.

Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.

Headache. 2012 Jan;52(1):57-67. doi: 10.1111/j.1526-4610.2011.02027.x. Epub 2011 Nov 11.

PMID:
22078129
11.

Improvement in migraine-specific quality of life in a clinical trial of rizatriptan.

Santanello NC, Polis AB, Hartmaier SL, Kramer MS, Block GA, Silberstein SD.

Cephalalgia. 1997 Dec;17(8):867-72; discussion 800.

PMID:
9453276
12.

Rizatriptan: an update of its use in the management of migraine.

Wellington K, Plosker GL.

Drugs. 2002;62(10):1539-74. Review.

PMID:
12093318
13.

Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.

Ho TW, Pearlman E, Lewis D, Hämäläinen M, Connor K, Michelson D, Zhang Y, Assaid C, Mozley LH, Strickler N, Bachman R, Mahoney E, Lines C, Hewitt DJ; Rizatriptan Protocol 082 Pediatric Migraine Study Group.

Cephalalgia. 2012 Jul;32(10):750-65. Epub 2012 Jun 18.

PMID:
22711898
14.

Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.

Christie S, Göbel H, Mateos V, Allen C, Vrijens F, Shivaprakash M; Rizatriptan-Ergotamine/Caffeine Preference Study Group.

Eur Neurol. 2003;49(1):20-9.

PMID:
12464714
15.

Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.

Seeburger JL, Taylor FR, Friedman D, Newman L, Ge Y, Zhang Y, Hustad CM, Lasorda J, Fan X, Hewitt D, Ho T, Connor KM.

Cephalalgia. 2011 May;31(7):786-96. doi: 10.1177/0333102410390399. Epub 2010 Nov 15.

PMID:
21078681
16.

Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.

Ferrari MD, Loder E, McCarroll KA, Lines CR.

Cephalalgia. 2001 Mar;21(2):129-36.

PMID:
11422095
17.

Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.

Savi L, Mogavero S, Egan CG.

Drug Des Devel Ther. 2014 Jul 21;8:983-92. doi: 10.2147/DDDT.S61295. eCollection 2014.

18.

WITHDRAWN: Rizatriptan for acute migraine.

Oldman AD, Smith LA, McQuay HJ, Moore RA.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD003221. Review.

PMID:
17636717
19.

Rizatriptan for acute migraine.

Oldman AD, Smith LA, McQuay HJ, Moore RA.

Cochrane Database Syst Rev. 2001;(3):CD003221. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD003221.

PMID:
11687054
20.

Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.

Freitag F, Diamond M, Diamond S, Janssen I, Rodgers A, Skobieranda F.

Headache. 2008 Jun;48(6):921-30.

PMID:
18572432

Supplemental Content

Support Center